Volume | 1,589,999 |
|
|||||
News | - | ||||||
Day High | 0.0005 | Low High |
|||||
Day Low | 0.0004 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Todos Med Ltd (PK) | TOMDF | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0004 | 0.0004 | 0.0005 | 0.0005 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
10 | 1,589,999 | $ 0.000429 | $ 682 | - | 0.0003 - 0.0196 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:51:21 | 20,000 | $ 0.0005 | USD |
Todos Med Ltd (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 1.28M | 2.57B | 607.86M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Todos Med (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOMDF Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0006 | 0.0006 | 0.0004 | 0.0005 | 12,196,907 | -0.0001 | -16.67% |
1 Month | 0.0007 | 0.0007 | 0.0004 | 0.0005232 | 9,151,243 | -0.0002 | -28.57% |
3 Months | 0.0007 | 0.0007 | 0.0003 | 0.0005026 | 9,882,224 | -0.0002 | -28.57% |
6 Months | 0.001 | 0.004 | 0.0003 | 0.0008127 | 10,648,199 | -0.0005 | -50.0% |
1 Year | 0.0193 | 0.0196 | 0.0003 | 0.0023997 | 10,635,751 | -0.0188 | -97.41% |
3 Years | 0.0733 | 0.644 | 0.0003 | 0.0221637 | 7,675,835 | -0.0728 | -99.32% |
5 Years | 0.15 | 0.644 | 0.0003 | 0.026558 | 5,444,391 | -0.1495 | -99.67% |
Todos Med (PK) Description
Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that examines cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally developed cancer-screening tests, TMB-1 and TMB-2 have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing, Long COVID Panel, and Provista's proprietary commercial-stage Videssa breast cancer blood test. |